Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jun 7, 2011

Premium

Jan Smilek has been named chief financial officer at Akonni Biosystems.

He most recently was CFO and treasurer of Sucampo Pharmaceuticals. He was also senior director of finance for Vanda Pharmaceuticals and served as a senior manager for PricewaterhouseCoopers.

Smilek holds a BS in economics from the School of Economics in Bratislava, Slovakia, and an MBA from Georgetown University.


Exosome Diagnostics has named new members to its scientific advisory board, including John Quackenbush, Bob Carter, Carlos Cordon-Cardo, and Keith Flaherty.

Quackenbush is a professor at Dana-Faber Cancer Institute's Department of Computational Biology and Bioinformatics. Carter is chief of neurosurgery at the University of California, San Diego; Cordon-Cardo is vice chairman of pathology and a professor of pathology and urology at Columbia University; and Flaherty is director of developmental therapeutics at the Massachusetts General Hospital Cancer Center.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.